Cyclopharm Limited (ASX:CYC)
Australia flag Australia · Delayed Price · Currency is AUD
1.045
+0.065 (6.63%)
Jul 11, 2025, 4:10 PM AEST

Cyclopharm Revenue

In the year 2024, Cyclopharm had annual revenue of 27.57M AUD with 4.68% growth. Cyclopharm had revenue of 14.37M in the half year ending December 31, 2024, with 6.87% growth.

Revenue
27.57M
Revenue Growth
+4.68%
P/S Ratio
4.21
Revenue / Employee
290.24K
Employees
95
Market Cap
116.14M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 27.57M 1.23M 4.68%
Dec 31, 2023 26.34M 1.48M 5.97%
Dec 31, 2022 24.85M 4.86M 24.30%
Dec 31, 2021 20.00M 2.31M 13.09%
Dec 31, 2020 17.68M 668.06K 3.93%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Ramsay Health Care 17.12B
Telix Pharmaceuticals 783.21M
Ansell 3.00B
Regis Healthcare 1.10B
Revenue Rankings